Literature DB >> 10484297

Late pouch dilation after laparoscopic adjustable gastric and esophagogastric banding: incidence, treatment, and outcome.

E Niville1, A Dams.   

Abstract

BACKGROUND: Pathologic late pouch dilation is the most frequent complication following gastric banding procedures for morbid obesity. In this study, possible predictive factors were sought. The treatment of these complications and the final outcome are discussed.
METHODS: Between December 1994 and December 1997, 171 patients underwent laparoscopic adjustable banding for morbid obesity. 40 patients underwent classic gastric banding (Group 1), and 131 patients underwent esophagogastric banding (Group 2).
RESULTS: Pouch dilation developed in 6 patients (15%) in Group 1 and 12 patients (9.2%) in Group 2. There were no significant predictive factors, although the complication occurred more frequently in patients with presurgical hiatus hernia. The type of dilation was different for each group, as was the surgical treatment. Laparoscopic repositioning of the band was always possible and was uncomplicated. The long-term outcome has been good, and weight loss has been maintained.
CONCLUSIONS: A frequent complication following banding procedures for morbid obesity is pathologic late pouch dilation. In experienced hands, when appropriate surgical treatment is carried out, this is not a major problem. Nevertheless, efforts should be made to decrease the number of late dilations.

Entities:  

Mesh:

Year:  1999        PMID: 10484297     DOI: 10.1381/096089299765552972

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  17 in total

1.  Laparoscopic Roux-en-Y gastric bypass, but not rebanding, should be proposed as rescue procedure for patients with failed laparoscopic gastric banding.

Authors:  Markus Weber; Markus K Müller; Jean-Marie Michel; Rahim Belal; Fritz Horber; Renward Hauser; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

2.  Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity.

Authors:  Markus Weber; Markus K Müller; Tanja Bucher; Stefan Wildi; Daniel Dindo; Fritz Horber; Rennward Hauser; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

3.  [Complications after adjustable gastric banding. Results of an inquiry in Germany].

Authors:  C Stroh; T Manger
Journal:  Chirurg       Date:  2006-03       Impact factor: 0.955

Review 4.  [Evidential basis in bariatric surgery].

Authors:  M K Müller; S Wildi; P-A Clavien; M Weber
Journal:  Chirurg       Date:  2005-07       Impact factor: 0.955

5.  Interdisciplinary European guidelines for surgery for severe (morbid) obesity.

Authors:  Martin Fried; Vojtech Hainer; Arnaud Basdevant; Henry Buchwald; Mervyn Deitel; Nicholas Finer; Jan Willem M Greve; Fritz Horber; Elisabeth Mathus-Vliegen; Nicola Scopinaro; Rudolf Steffen; Constantine Tsigos; Rudolf Weiner; Kurt Widhalm
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

6.  Interdisciplinary European guidelines on metabolic and bariatric surgery.

Authors:  M Fried; V Yumuk; J M Oppert; N Scopinaro; A Torres; R Weiner; Y Yashkov; G Frühbeck
Journal:  Obes Surg       Date:  2014-01       Impact factor: 4.129

7.  Quality of life following laparoscopic gastric banding in patients with morbid obesity.

Authors:  S M Freys; H Tigges; J Heimbucher; K H Fuchs; M Fein; A Thiede
Journal:  J Gastrointest Surg       Date:  2001 Jul-Aug       Impact factor: 3.452

8.  Gastrointestinal issues in the assessment and management of the obese patient.

Authors:  Zulfiqar Hussain; Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-07

Review 9.  Biliopancreatic diversion in the surgical treatment of morbid obesity.

Authors:  Robrecht H G G Van Hee
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

10.  Efficacy of a laparoscopic gastric restrictive device in an obese canine model.

Authors:  Xiaomei Guo; Samer G Mattar; Scott E Mimms; Jose A Navia; Ghassan S Kassab
Journal:  Obes Surg       Date:  2014-01       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.